Mineralys Therapeutics
Adrianne D. Rush is an experienced professional in quality management and regulatory systems, currently serving as the Director of Quality Management Systems at Mineralys Therapeutics, Inc. since April 2023. Previously, Adrianne held the position of Associate Director of Project Management, Quality and Regulatory Systems at Galera Therapeutics, Inc. from May 2020 to April 2023. Adrianne's extensive background includes roles at Johnson & Johnson in various capacities, including Manager of Quality & Compliance Strategic Program Management and Project Manager in Quality Systems & Compliance for medical devices, where notable achievements include optimizing supplier processes and leading global cross-functional projects. Adrianne has also provided significant expertise in records management as a Senior Consultant for Paragon Solutions and managed Document Management programs at Centocor Research and Development. Adrianne began the professional career at GlaxoSmithKline as a Team Leader in Document Management. Adrianne holds a Bachelor of Science degree in Biology from Chestnut Hill College.
This person is not in any teams
This person is not in any offices
Mineralys Therapeutics
2 followers
At Mineralys Therapeutics, they aim to redefine hypertension diagnosis, management, and treatment. They are driven to break the “trial and failure” approach to hypertension management and bring a personalized approach to the management of hypertension.